MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 256 filers reported holding MIRATI THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.67 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,409,593 | -69.6% | 147,144 | -74.8% | 0.01% | -68.3% |
| Q2 2023 | $21,111,590 | +2.8% | 584,323 | +5.7% | 0.04% | -6.8% |
| Q1 2023 | $20,546,189 | +68.0% | 552,614 | +562.9% | 0.04% | +91.3% |
| Q4 2021 | $12,229,000 | +71.8% | 83,364 | +107.2% | 0.02% | -23.3% |
| Q3 2021 | $7,117,000 | -1.4% | 40,232 | -10.0% | 0.03% | -9.1% |
| Q2 2021 | $7,221,000 | -11.3% | 44,702 | -6.0% | 0.03% | -10.8% |
| Q1 2021 | $8,144,000 | -90.0% | 47,544 | -87.2% | 0.04% | -91.6% |
| Q4 2020 | $81,401,000 | +14.4% | 370,606 | -13.5% | 0.44% | -3.1% |
| Q3 2020 | $71,136,000 | +7279.3% | 428,399 | +5625.7% | 0.46% | +6400.0% |
| Q4 2019 | $964,000 | +35.4% | 7,482 | -22.9% | 0.01% | +133.3% |
| Q1 2019 | $712,000 | +8800.0% | 9,706 | +4753.0% | 0.00% | – |
| Q4 2018 | $8,000 | -97.0% | 200 | -97.7% | 0.00% | -100.0% |
| Q1 2018 | $268,000 | – | 8,740 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
| EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
| Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
| RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
| Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
| Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
| Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
| Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
| Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |